Literature DB >> 23767666

Randomized controlled trials in endourology: a quality assessment.

Jung Ki Jo1, Riccardo Autorino, Jae Hoon Chung, Kyu Shik Kim, Jeong Woo Lee, Eun Jung Baek, Seung Wook Lee.   

Abstract

PURPOSE: To analyze the quality of studies reporting randomized clinical trials (RCTs) in the field of endourology.
MATERIALS AND METHODS: RCTs published in the Journal of Endourology from 1993 until 2011 were identified. The Jadad scale, van Tulder scale, and Cochrane Collaboration Risk of Bias Tool (CCRBT) were used to assess the quality of the studies. The review period was divided into early (1993-1999), mid (2000-2005), and late (2006-2011) terms. Studies were categorized by country of origin, subject matter, single- vs multicenter setting, Institutional Review Board (IRB) approval and funding support, and blinding vs nonblinding.
RESULTS: In total, 3339 articles had been published during the defined review period, of which 165 articles were reporting a RCT. There was a significant increase in the number of RCTs published over time, with 18 (2.81%), 43 (4.88%), and 104 (5.72%) studies identified in the early, mid, and late term, respectively (P=0.009). Nevertheless, there was no difference in terms of quality of reporting, as assessed with the Jadad scale, van Tulder scale, or CCRBT, between the three study terms. On the other hand, significant differences were found in both the number of high qualitative RCTs that used blinding methodology and those that had IRB review, when comparing the early, mid, and late terms.
CONCLUSION: There has been a growing number of Journal of Endourology publications reporting on RTC over the last two decades. The quality of reporting for these studies remains suboptimal, however. Researchers should focus on a more appropriate description of key features of any given RCT, such as randomization and allocation methods, as well as disclosure of IRB review and financial support.

Entities:  

Mesh:

Year:  2013        PMID: 23767666      PMCID: PMC3741436          DOI: 10.1089/end.2013.0036

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  21 in total

Review 1.  Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Authors:  P Jüni; D G Altman; M Egger
Journal:  BMJ       Date:  2001-07-07

2.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  David Moher; Kenneth F Schulz; Douglas G Altman
Journal:  Clin Oral Investig       Date:  2003-01-31       Impact factor: 3.573

3.  Randomized clinical trials presented at the World Congress of Endourology: how is the quality of reporting?

Authors:  Riccardo Autorino; Claudio Borges; Michael A White; Fatih Altunrende; Sisto Perdoná; Georges-Pascal Haber; Marco De Sio; Rakesh Khanna; Robert J Stein; Jihad H Kaouk
Journal:  J Endourol       Date:  2010-09-28       Impact factor: 2.942

4.  Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors.

Authors:  Douglas G Altman
Journal:  BMJ       Date:  2005-05-07

Review 5.  Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.

Authors:  Charles D Scales; Regina D Norris; Glenn M Preminger; Johannes Vieweg; Bercedis L Peterson; Philipp Dahm
Journal:  J Urol       Date:  2008-08-16       Impact factor: 7.450

6.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

7.  Evidence based general practice: a retrospective study of interventions in one training practice.

Authors:  P Gill; A C Dowell; R D Neal; N Smith; P Heywood; A E Wilson
Journal:  BMJ       Date:  1996-03-30

8.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

9.  Bias in treatment assignment in controlled clinical trials.

Authors:  T C Chalmers; P Celano; H S Sacks; H Smith
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

10.  Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.

Authors:  Tammy J Clifford; Nicholas J Barrowman; David Moher
Journal:  BMC Health Serv Res       Date:  2002-09-04       Impact factor: 2.655

View more
  3 in total

1.  Quality analysis of randomized controlled trials in the International Journal of Impotence Research: quality assessment and relevant clinical impact.

Authors:  K S Kim; J K Jo; J H Chung; J H Kim; H Y Choi; S W Lee
Journal:  Int J Impot Res       Date:  2016-12-01       Impact factor: 2.896

2.  Analysis of randomized controlled trials in Rheumatology International from 1981 to 2012: methodological assessment.

Authors:  Jeong Woo Lee; Jae Hoon Chung; Jung Ki Jo; Seung Wook Lee
Journal:  Rheumatol Int       Date:  2014-02-25       Impact factor: 2.631

Review 3.  Compliance of Published Randomized Controlled Trials on the Effect of Physical Activity on Primary Dysmenorrhea with the Consortium's Integrated Report on Clinical Trials Statement: A Critical Appraisal of the Literature.

Authors:  Elham Manouchehri; Somayeh Alirezaei; Robab Latifnejad Roudsari
Journal:  Iran J Nurs Midwifery Res       Date:  2020-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.